A comparative clinical study of NÄ?gakesara CÅ«rnÌ£a and KutakÄ« CÅ«rnÌ£a in the management of AsrÌ£gdara with special reference to Dysfunctional Uterine Bleeding.

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1) Patients ready to participate in the clinical trial.
•2) Patients diagnosed as dysfunctional uterine bleeding.
•3) Excessive menstrual bleeding (amount >80 ml) or Prolonged menstrual bleeding ( >7 days) with or without heavy flow or Frequent menstrual cycle (interval < 21 days)
•4) Patients presenting with inter-menstrual bleeding with or without heavy flow for 2 consecutive cycles.

•1) Patients with chronic systemic illness (Congestive cardiac failure, Hypertension, cirrhosis of liver, Tuberculosis endometritis, severe anaemia, chronic renal disease, Insulin dependent diabetes mellitus etc.).
•2) Patients using Intrauterine contraceptive device or oral contraceptive pills (Iatrogenic).
•3) Patients with uterine and pelvic pathology (Fibroid size >2 cm, endometriosis, adenomyosis, polyp, high grade cervical erosion, endometrial thickness >20 mm etc.).
•4) Congenital malformations of uterus(Septate uterus, double uterus).
•5) Benign and malignant growth.
•6) Thyroid dysfunction (endocrinal disorders).
•7) Patients having bleeding due to abortion, ectopic pregnancy, during puerperium.
•8) Patients taking Anti-coagulation therapy and having haematological disorders (Leukemia, Thrombocytopenic Purpura).
•9) Postmenopausal bleeding.
•10) Sexually transmitted infections/Genital tract infections.

发起方